Fabrication of nanoformulation containing carvedilol and silk protein sericin against doxorubicin induced cardiac damage in rats

HIGHLIGHTS

  • who: Mohammad Shariq and colleagues from the Department of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India have published the research work: Fabrication of Nanoformulation Containing Carvedilol and Silk Protein Sericin against Doxorubicin Induced Cardiac Damage in Rats, in the Journal: Pharmaceuticals 2023, 16, 561. of 18/03/2023
  • what: This study focuses on the assessment of the cardioprotective prospective ofanovel combination nanoformulation of and is a obtained from Bombyx mori cocoon and is a synthetic nonselective u03b2-blocker. Using the approach described by Aebi , the characteristics of catalase were assessed.

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?